Treatment Against Atypical Pathogens Vital To Improvement In Hospitalized Community-Acquired Pneumonia Patients
Hospitalized patients with community-acquired pneumonia (CAP) who received treatment regimens against atypical disease-causing pathogens reached clinical stability quicker, had fewer days of hospitalization, and had lower mortality rates as a result of their disease, according to a large new study.



